시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 진단용 AI 시장 보고서(2025년)
Artificial Intelligence In The Diagnostic Global Market Report 2025
상품코드 : 1824590
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

진단용 AI 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 39.4%를 나타내 225억 1,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 맞춤형 의료 동향, 건강 관리 데이터의 급속한 증가, 세계 건강 과제, 투자 증가, 건강 관리 시스템과의 통합 강화 등으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향에는 연계와 투자, 기술 진보, 데이터 프라이버시와 보안에 대한 우려, 설명 가능한 AI(xai)의 상승, 컴퓨터 비전의 역할 확대 등이 있습니다.

향후 5년간의 성장률 39.4%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 이스라엘과 영국에서 조달한 인공지능(AI) 탑재의 감별 진단 플랫폼과 증상 검사기 알고리즘의 비용을 상승시킴으로써 미국의 진단 정밀도를 저해하고, 임상적 의사결정을 늦추고, 헬스케어 시스템의 지출을 증가시킬 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

진단용 AI의 예상 성장은 만성 질환의 유병률 증가로 인한 것입니다. 만성 질환은 이환 기간이 긴 것이 특징이며, 개인의 생애에 걸쳐 지속되는 지속적인 건강 과제입니다. 만성 질환 관리에서 AI 기반 진단 프로세스의 통합은 조기 발견, 예측, 의사결정 지원 시스템 개선, 원격 환자 모니터링, 비용 절감, 유전적 체질 및 질병 진행에 기초한 개별 환자에 맞는 치료 계획 등의 이점을 제공합니다. 2023년 9월 기준 세계보건기구(WHO)는 전 세계의 비감염성 질환(NCD) 또는 만성 질환 관련 사망률의 74%를 차지하는 연간 사망자 수 4,100만 명을 보고했습니다. 특히 심혈관질환이 1,790만명, 암이 930만명, 만성호흡기질환이 410만명, 당뇨병이 200만명을 차지하고 있습니다. 그러므로 만성질환의 만연의 확대는 진단용 AI의 성장을 지원하는 중요한 요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

AI in diagnostics involves the application of artificial intelligence (AI) technologies in medical diagnosis, utilizing advanced algorithms, machine learning, and data analysis techniques to interpret medical data, images, and clinical information. The purpose of implementing AI in diagnostics is to enhance the accuracy, speed, and efficiency of medical diagnoses.

The primary components of AI in the diagnostic market include hardware, software, and services. Hardware pertains to the physical parts of a computer system or other electronic device. In AI in diagnostics, hardware plays a crucial role in improving processing power, enabling real-time analysis, ensuring scalability, facilitating integration with imaging devices, enhancing energy efficiency, ensuring security, promoting interoperability, customization, and reliability. These factors collectively contribute to more effective and efficient diagnostic processes in healthcare. Various technologies, including machine learning, natural language processing (NLP), context-aware computing, and computer vision, find application in various diagnostic types such as radiology, pathology, cardiology, oncology, neurology, chest and lung, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial intelligence in the diagnostic market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in the diagnostic market statistics, including the artificial intelligence in the diagnostic industry global market size, regional shares, competitors with artificial intelligence in the diagnostic market share, detailed artificial intelligence in the diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in the diagnostic industry. This artificial intelligence in the diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in the diagnostic market size has grown exponentially in recent years. It will grow from $4.29 billion in 2024 to $5.97 billion in 2025 at a compound annual growth rate (CAGR) of 39.1%. The growth in the historic period can be attributed to rising disease burden, data availability, cost reduction, regulatory support, increasing awareness.

The artificial intelligence in the diagnostic market size is expected to see exponential growth in the next few years. It will grow to $22.51 billion in 2029 at a compound annual growth rate (CAGR) of 39.4%. The growth in the forecast period can be attributed to personalized medicine trends, rapid increase in healthcare data, global health challenges, increased investments, enhanced integration with healthcare systems. Major trends in the forecast period include collaboration and investment, advancements in technology, data privacy and security concerns, rise of explainable ai (xai), expanding role of computer vision.

The forecast of 39.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. diagnostic accuracy by increasing the cost of Artificial intelligence(AI)-powered differential diagnosis platforms and symptom checker algorithms sourced from Israel and the UK, thereby delaying clinical decision-making and elevating healthcare system expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of AI in the diagnostics market is attributed to the increasing prevalence of chronic diseases. Chronic diseases, characterized by their prolonged duration, present a persistent health challenge lasting for an individual's lifetime. The integration of AI-based diagnostic processes in managing chronic diseases offers advantages such as early detection, prediction, improved decision support systems, remote patient monitoring, cost reduction, and personalized treatment plans tailored to individual patients based on their genetic makeup and disease progression. As of September 2023, the World Health Organization reported 41 million annual fatalities, constituting 74% of global non-communicable disease (NCD) or chronic disease-related deaths. Notably, cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2.0 million deaths. Therefore, the escalating prevalence of chronic diseases is a key driver behind the growth of AI in the diagnostics market.

Major companies in the AI in diagnostics market are actively engaged in developing cutting-edge technologies, including AI modules, to enhance their market competitiveness. An AI module, defined as a self-contained software component housing specific AI capabilities or functionalities, plays a pivotal role in this landscape. For example, in March 2023, Qritive, a Singapore-based provider of AI-powered solutions, introduced QAI Prostate, designed for prostate cancer diagnosis. This innovative solution efficiently identifies the most common form of prostate cancer, potentially enhancing diagnostic accuracy and reducing false positives. QAI Prostate assists pathologists in distinguishing cancerous from non-cancerous tissue areas, facilitating informed treatment decisions. Additionally, the tool streamlines case prioritization for faster diagnosis and reporting, contributing to improved efficiency and patient care.

In June 2024, Quest Diagnostics Inc., a US-based provider of diagnostic information services, acquired the assets of PathAI Diagnostics for an undisclosed amount. This acquisition enables Quest Diagnostics to enhance its capabilities in AI and digital pathology, particularly in cancer diagnosis, by integrating PathAI's innovative technologies with its existing diagnostic services. PathAI Inc. is a US-based company known for providing advanced AI and digital pathology solutions, specializing in improving diagnostic accuracy for biopharmaceutical companies and pathology laboratories. This move strengthens Quest Diagnostics' position in leveraging AI to deliver more precise and efficient healthcare solutions.

Major companies operating in the artificial intelligence in the diagnostic market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Paige.AI Inc., HeartFlow Inc., Aidoc Medical Ltd., AliveCor Inc., Butterfly Network Inc., Imagen Technologies, Digital Diagnostics Inc., Brainomix Ltd., NovaSignal Corp., Enlitic Inc., Nano-X Imaging LTD., EchoNous Inc., Zebra Medical Vision Ltd., Aidence B.V., Neural Analytics Inc., IDx Technologies Inc., icometrix N.V., Vuno Inc.

North America was the largest region in the artificial intelligence in diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in the diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI in diagnostics market consists of revenues earned by entities by providing services such as medical imaging analysis, disease prediction, and genomic sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in diagnostics market also includes sales of AI-powered imaging systems, AI-driven pathology tools, and point-of-care diagnostic devices Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In The Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in the diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for artificial intelligence in the diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in the diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Artificial Intelligence In The Diagnostic Market Characteristics

3. Artificial Intelligence In The Diagnostic Market Trends And Strategies

4. Artificial Intelligence In The Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Artificial Intelligence In The Diagnostic Growth Analysis And Strategic Analysis Framework

6. Artificial Intelligence In The Diagnostic Market Segmentation

7. Artificial Intelligence In The Diagnostic Market Regional And Country Analysis

8. Asia-Pacific Artificial Intelligence In The Diagnostic Market

9. China Artificial Intelligence In The Diagnostic Market

10. India Artificial Intelligence In The Diagnostic Market

11. Japan Artificial Intelligence In The Diagnostic Market

12. Australia Artificial Intelligence In The Diagnostic Market

13. Indonesia Artificial Intelligence In The Diagnostic Market

14. South Korea Artificial Intelligence In The Diagnostic Market

15. Western Europe Artificial Intelligence In The Diagnostic Market

16. UK Artificial Intelligence In The Diagnostic Market

17. Germany Artificial Intelligence In The Diagnostic Market

18. France Artificial Intelligence In The Diagnostic Market

19. Italy Artificial Intelligence In The Diagnostic Market

20. Spain Artificial Intelligence In The Diagnostic Market

21. Eastern Europe Artificial Intelligence In The Diagnostic Market

22. Russia Artificial Intelligence In The Diagnostic Market

23. North America Artificial Intelligence In The Diagnostic Market

24. USA Artificial Intelligence In The Diagnostic Market

25. Canada Artificial Intelligence In The Diagnostic Market

26. South America Artificial Intelligence In The Diagnostic Market

27. Brazil Artificial Intelligence In The Diagnostic Market

28. Middle East Artificial Intelligence In The Diagnostic Market

29. Africa Artificial Intelligence In The Diagnostic Market

30. Artificial Intelligence In The Diagnostic Market Competitive Landscape And Company Profiles

31. Artificial Intelligence In The Diagnostic Market Other Major And Innovative Companies

32. Global Artificial Intelligence In The Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In The Diagnostic Market

34. Recent Developments In The Artificial Intelligence In The Diagnostic Market

35. Artificial Intelligence In The Diagnostic Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기